Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Ebiomedicine|June 7, 2021
Accuracy of four lateral flow immunoassays for anti SARS-CoV-2 antibodies: a head-to-head comparative studyHayley E Jones, Ranya Mulchandani, Sian Taylor-Phillips, et al.
Emerging Infectious Diseases|September 25, 2024
Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023Ameeka Thompson, Tim Brooks, Catherine Houlihan, et al.
Emerging Infectious Diseases|June 21, 2021
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UKGayatri Amirthalingam, Heather Whitaker, Tim Brooks, et al.
Ebiomedicine|February 13, 2016
Whole Genome Analysis of Injectional Anthrax Identifies Two Disease Clusters Spanning More Than 13 YearsPaul Keim, Roland Grunow, Richard Vipond, et al.
Nature Communications|August 23, 2023
Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunityDaniel M Altmann, Catherine J Reynolds, George Joy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 7, 2025
Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023Helen Callaby, Kate R Beard, Dominic Wakerley, et al.
The Journal of Infection|March 29, 2021
Association between self-reported signs and symptoms and SARS-CoV-2 antibody detection in UK key workersRanya Mulchandani, Sian Taylor-Philips, Hayley E Jones, et al.
Lancet (London, England)|June 30, 2015
ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation studyMara Jana Broadhurst, John Daniel Kelly, Ann Miller, et al.
Transfusion|August 3, 2021
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to predictionAbigail Lamikanra, Dung Nguyen, Peter Simmonds, et al.
The Lancet. Respiratory Medicine|June 30, 2022
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trialAbhishek Abhishek, Rosemary J Boyton, Nicholas Peckham, et al.
Pageof 7